Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic

Thomas Zeller; Elias Noory; Ulrich Beschorner; Tanja Böhme; Michel M.P.J. Reijnen

doi:10.1024/0301-1526/a000778

Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic

Thomas Zeller^*, Elias Noory, Ulrich Beschorner, Tanja Böhme, Michel M.P.J. Reijnen

^*Corresponding author for this work

Multi-Modality Medical Imaging

Research output: Contribution to journal › Editorial › Academic › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	109-111
Number of pages	3
Journal	Vasa - European Journal of Vascular Medicine
Volume	48
Issue number	2
DOIs	https://doi.org/10.1024/0301-1526/a000778
Publication status	Published - Mar 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1024/0301-1526/a000778

Cite this

Zeller, T., Noory, E., Beschorner, U., Böhme, T., & Reijnen, M. M. P. J. (2019). Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic. Vasa - European Journal of Vascular Medicine, 48(2), 109-111. https://doi.org/10.1024/0301-1526/a000778

@article{48bd9f7588ca46949adc52477525f6c8,

title = "Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic",

author = "Thomas Zeller and Elias Noory and Ulrich Beschorner and Tanja B{\"o}hme and Reijnen, {Michel M.P.J.}",

year = "2019",

month = mar,

doi = "10.1024/0301-1526/a000778",

language = "English",

volume = "48",

pages = "109--111",

journal = "Vasa - European Journal of Vascular Medicine",

issn = "0301-1526",

publisher = "Verlag Hans Huber",

number = "2",

}

Zeller, T, Noory, E, Beschorner, U, Böhme, T & Reijnen, MMPJ 2019, 'Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic', Vasa - European Journal of Vascular Medicine, vol. 48, no. 2, pp. 109-111. https://doi.org/10.1024/0301-1526/a000778

Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic. / Zeller, Thomas; Noory, Elias; Beschorner, Ulrich et al.
In: Vasa - European Journal of Vascular Medicine, Vol. 48, No. 2, 03.2019, p. 109-111.

Research output: Contribution to journal › Editorial › Academic › peer-review

TY - JOUR

T1 - Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic

AU - Zeller, Thomas

AU - Noory, Elias

AU - Beschorner, Ulrich

AU - Böhme, Tanja

AU - Reijnen, Michel M.P.J.

PY - 2019/3

Y1 - 2019/3

UR - http://www.scopus.com/inward/record.url?scp=85065287259&partnerID=8YFLogxK

U2 - 10.1024/0301-1526/a000778

DO - 10.1024/0301-1526/a000778

M3 - Editorial

C2 - 30821214

AN - SCOPUS:85065287259

SN - 0301-1526

VL - 48

SP - 109

EP - 111

JO - Vasa - European Journal of Vascular Medicine

JF - Vasa - European Journal of Vascular Medicine

IS - 2

ER -

Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic

UN SDGs

Access to Document

Other files and links

Cite this